Browse by Changes
Summary of Changes – 1 May 2024
Page last updated: 1 May 2024
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Deletions
Deletion – Item
13625D | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit (Germany)) |
3485K | PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes (Cilicaine) |
Deletion – Equivalence Indicator
3467L | GlucaGen Hypokit, NO – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
Deletion – Note
3467L | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit) |
Advance Notices
1 July 2024
Deletion – Brand
12108G | Asmol CFC-Free with dose counter, AF – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
12108G | Zempreon CFC-Free with dose counter, AL – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
General Pharmaceutical Benefits
Additions
Addition – Item
14116Y | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
14105J | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
14134X | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
14118C | AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE, ISOLEUCINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals without valine, leucine, isoleucine and supplemented with arachidonic acid and docosahexaenoic acid containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets (MSUD explore5) |
14114W | AMINO ACID FORMULA WITH VITAMINS AND MINERALS, WITHOUT METHIONINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals, without methionine and supplemented with arachidonic acid and docosahexaenoic acid containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets (HCU explore5) |
14126L | AMINO ACID FORMULA WITH VITAMINS AND MINERALS, WITHOUT PHENYLALANINE, TYROSINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals, without phenylalanine, tyrosine and supplemented with arachidonic acid and docosahexaenoic acid containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets (TYR explore5) |
14132T | COLESTYRAMINE, colestyramine 4 g powder for oral liquid, 60 pouches (Cholestyramine (Ascend, USA)) |
14145L | COLESTYRAMINE, colestyramine 4 g powder for oral liquid, 60 pouches (Cholestyramine (Ascend, USA)) |
14123H | MAVACAMTEN, mavacamten 2.5 mg capsule, 28 (Camzyos) |
14135Y | MAVACAMTEN, mavacamten 2.5 mg capsule, 28 (Camzyos) |
14113T | MAVACAMTEN, mavacamten 5 mg capsule, 28 (Camzyos) |
14117B | MAVACAMTEN, mavacamten 5 mg capsule, 28 (Camzyos) |
14137C | MAVACAMTEN, mavacamten 10 mg capsule, 28 (Camzyos) |
14138D | MAVACAMTEN, mavacamten 10 mg capsule, 28 (Camzyos) |
14124J | MAVACAMTEN, mavacamten 15 mg capsule, 28 (Camzyos) |
14139E | MAVACAMTEN, mavacamten 15 mg capsule, 28 (Camzyos) |
14108M | PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 250 (Stemetil (Ireland)) |
14129P | PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 250 (Stemetil (Ireland)) |
14111Q | RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi) |
14142H | RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi) |
14100D | TAFAMIDIS, tafamidis 61 mg capsule, 30 (Vyndamax) |
14125K | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
Addition – Brand
9318K | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
9320M | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 75 mg capsule, 60 |
9322P | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
13523R | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
2753X | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
9319L | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 110 mg capsule, 10 |
9321N | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
9323Q | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 110 mg capsule, 10 |
13489Y | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60 |
2769R | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60 |
13412X | ARX-LERCANIDIPINE, TX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
8679T | ARX-LERCANIDIPINE, TX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
2272N | Chexate, OX – METHOTREXATE, methotrexate 10 mg tablet, 15 |
8144P | Sumagraine Migraine Relief, GQ – SUMATRIPTAN, sumatriptan 50 mg tablet, 2 |
13907Y | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
5299X | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
13962W | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
5300Y | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11914C | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
13996P | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
14039X | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
5451X | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
14093R | Teriparatide Lupin, GQ – TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL pen device |
14017R | APO-Sodium Valproate, TX – VALPROATE, valproate sodium 200 mg enteric tablet, 100 |
2289L | APO-Sodium Valproate, TX – VALPROATE, valproate sodium 200 mg enteric tablet, 100 |
13917L | APO-Sodium Valproate, TX – VALPROATE, valproate sodium 500 mg enteric tablet, 100 |
2290M | APO-Sodium Valproate, TX – VALPROATE, valproate sodium 500 mg enteric tablet, 100 |
Addition – Equivalence Indicator
9318K | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
9322P | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
9319L | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 110 mg capsule, 10 |
9323Q | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 110 mg capsule, 10 |
2272N | Methoblastin, PF – METHOTREXATE, methotrexate 10 mg tablet, 15 |
13907Y | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
5299X | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
13962W | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
5300Y | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11914C | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
13996P | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
14039X | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
5451X | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
Addition – Note
2893G | PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 25 (APO-Prochlorperazine, ProCalm, Prochlorperazine GH, Stemetil) |
5205Y | PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 25 (APO-Prochlorperazine, ProCalm, Prochlorperazine GH, Stemetil) |
Deletions
Deletion – Item
5484P | AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 25 g sachets (GA express 15) |
13278W | CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL (Keforal) |
13285F | CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL (Keforal) |
11191B | CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 100 mL (Zinnat) |
11192C | CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 100 mL (Zinnat) |
13612K | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit (Germany)) |
13614M | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit (Germany)) |
13279X | MINOXIDIL, minoxidil 10 mg tablet, 60 (Minoxidil 10 mg (Roma Pharmaceuticals)) |
1794K | PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes (Cilicaine) |
3371K | PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes (Cilicaine) |
Deletion – Brand
13532F | Norvapine, ED – AMLODIPINE, amlodipine 5 mg tablet, 30 |
2751T | Norvapine, ED – AMLODIPINE, amlodipine 5 mg tablet, 30 |
13562T | Norvapine, ED – AMLODIPINE, amlodipine 10 mg tablet, 30 |
2752W | Norvapine, ED – AMLODIPINE, amlodipine 10 mg tablet, 30 |
13179P | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13179P | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13190F | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13190F | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13194K | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13194K | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
3172Y | Risperidone generichealth, GQ – RISPERIDONE, risperidone 4 mg tablet, 60 |
11296M | Tenofovir Disoproxil Emtricitabine Mylan 300/200, AF – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 |
13969F | Topamax, JC – TOPIRAMATE, topiramate 25 mg tablet, 60 |
8163P | Topamax, JC – TOPIRAMATE, topiramate 25 mg tablet, 60 |
13913G | Topamax, JC – TOPIRAMATE, topiramate 50 mg tablet, 60 |
8164Q | Topamax, JC – TOPIRAMATE, topiramate 50 mg tablet, 60 |
14008G | Topamax, JC – TOPIRAMATE, topiramate 100 mg tablet, 60 |
8165R | Topamax, JC – TOPIRAMATE, topiramate 100 mg tablet, 60 |
14009H | Topamax, JC – TOPIRAMATE, topiramate 200 mg tablet, 60 |
8166T | Topamax, JC – TOPIRAMATE, topiramate 200 mg tablet, 60 |
10785P | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
2666H | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
2922T | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
Deletion – Equivalence Indicator
1449G | GlucaGen Hypokit, NO – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
5105Q | GlucaGen Hypokit, NO – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
2313R | Loniten, PF – MINOXIDIL, minoxidil 10 mg tablet, 100 |
Deletion – Note
3095X | CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL (Cefalexin Sandoz, Ibilex 250, Keflex) |
3320R | CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL (Cefalexin Sandoz, Ibilex 250, Keflex) |
13202W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
13177M | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13183W | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
1449G | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit) |
5105Q | GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack (GlucaGen Hypokit) |
2313R | MINOXIDIL, minoxidil 10 mg tablet, 100 (Loniten) |
13171F | TEPOTINIB, tepotinib 225 mg tablet, 60 (Tepmetko) |
13181R | VERICIGUAT, vericiguat 2.5 mg tablet, 28 (Verquvo) |
13186B | VERICIGUAT, vericiguat 5 mg tablet, 28 (Verquvo) |
13193J | VERICIGUAT, vericiguat 10 mg tablet, 28 (Verquvo) |
Deletion – Restriction
13202W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
13177M | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13183W | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
13171F | TEPOTINIB, tepotinib 225 mg tablet, 60 (Tepmetko) |
13181R | VERICIGUAT, vericiguat 2.5 mg tablet, 28 (Verquvo) |
13186B | VERICIGUAT, vericiguat 5 mg tablet, 28 (Verquvo) |
13193J | VERICIGUAT, vericiguat 10 mg tablet, 28 (Verquvo) |
Alterations
Alteration – Note
11876C | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
11871T | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
11868P | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
12818P | PALBOCICLIB, palbociclib 75 mg tablet, 21 (Ibrance) |
12819Q | PALBOCICLIB, palbociclib 100 mg tablet, 21 (Ibrance) |
12822W | PALBOCICLIB, palbociclib 125 mg tablet, 21 (Ibrance) |
13864Q | PERAMPANEL, perampanel 4 mg tablet, 28 (Fycompa) |
14046G | PERAMPANEL, perampanel 6 mg tablet, 28 (Fycompa) |
11385F | RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali) |
11386G | RIBOCICLIB, ribociclib 200 mg tablet, 63 (Kisqali) |
11397W | RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali) |
Alteration – Restriction
11876C | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
11871T | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
11868P | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
12607M | ALIROCUMAB, alirocumab 75 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12608N | ALIROCUMAB, alirocumab 150 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
11985T | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
11986W | EVOLOCUMAB, evolocumab 420 mg/3.5 mL injection, 3.5 mL cartridge (Repatha) |
13079J | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
13089X | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
14088L | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
14094T | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
8233H | ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL (Zofran syrup 50 mL) |
1594X | ONDANSETRON, ondansetron 4 mg tablet, 10 (APO-Ondansetron, APX-Ondansetron, Ondansetron Mylan Tablets, Ondansetron SZ, Ondansetron-DRLA, Zofran, Zotren 4) |
5472B | ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 10 (APX-Ondansetron ODT, Ondansetron Mylan ODT, Ondansetron ODT Lupin, Ondansetron ODT-DRLA, Ondansetron SZ ODT, Zotren ODT) |
1595Y | ONDANSETRON, ondansetron 8 mg tablet, 10 (APO-Ondansetron, APX-Ondansetron, Ondansetron Mylan Tablets, Ondansetron SZ, Ondansetron-DRLA, Zofran, Zotren 8) |
5473C | ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 10 (APX-Ondansetron ODT, Ondansetron Mylan ODT, Ondansetron ODT Lupin, Ondansetron ODT-DRLA, Ondansetron SZ ODT, Zotren ODT) |
8412R | ONDANSETRON, ondansetron 4 mg wafer, 10 (Zofran Zydis) |
8413T | ONDANSETRON, ondansetron 8 mg wafer, 10 (Zofran Zydis) |
12818P | PALBOCICLIB, palbociclib 75 mg tablet, 21 (Ibrance) |
12819Q | PALBOCICLIB, palbociclib 100 mg tablet, 21 (Ibrance) |
12822W | PALBOCICLIB, palbociclib 125 mg tablet, 21 (Ibrance) |
11385F | RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali) |
11386G | RIBOCICLIB, ribociclib 200 mg tablet, 63 (Kisqali) |
11397W | RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali) |
11979L | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
Alteration – Manufacturer Code
From | To | ||
2122Q | Ordine 2 – MORPHINE, morphine hydrochloride trihydrate 2 mg/mL oral liquid, 200 mL | MF | XT |
5237P | Ordine 2 – MORPHINE, morphine hydrochloride trihydrate 2 mg/mL oral liquid, 200 mL | MF | XT |
2123R | Ordine 5 – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL | MF | XT |
5238Q | Ordine 5 – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL | MF | XT |
2124T | Ordine 10 – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL | MF | XT |
5239R | Ordine 10 – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL | MF | XT |
Alteration – Number of Repeats
From | To | ||
14087K | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | 1 | 0 |
13864Q | PERAMPANEL, perampanel 4 mg tablet, 28 (Fycompa) | 2 | 5 |
14046G | PERAMPANEL, perampanel 6 mg tablet, 28 (Fycompa) | 2 | 5 |
Supply Only
When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.
Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.
Further information on Supply Only arrangements is available at https://www.pbs.gov.au/browse/medicine-listing/supply-only
Supply Only Commencing 1 May 2024
8361C | CAPECITABINE, capecitabine 150 mg tablet, 60 (Capecitabine-DRLA) |
5502N | CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg ampoules (Poly Gel) |
8514D | CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg ampoules (Poly Gel) |
5521N | DEXTRAN-70 + HYPROMELLOSE, dextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL ampoules (Bion Tears) |
8299T | DEXTRAN-70 + HYPROMELLOSE, dextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL ampoules (Bion Tears) |
1438Q | FLUOROMETHOLONE ACETATE, fluorometholone acetate 0.1% eye drops, 5 mL (Flarex) |
5533F | FLUOROMETHOLONE ACETATE, fluorometholone acetate 0.1% eye drops, 5 mL (Flarex) |
11827L | RISANKIZUMAB, risankizumab 75 mg/0.83 mL injection, 2 x 0.83 mL syringes (Skyrizi) |
11858D | RISANKIZUMAB, risankizumab 75 mg/0.83 mL injection, 2 x 0.83 mL syringes (Skyrizi) |
Advance Notices
1 June 2024
Deletion – Brand
13858J | Arimidex, AP – ANASTROZOLE, anastrozole 1 mg tablet, 30 |
8179L | Arimidex, AP – ANASTROZOLE, anastrozole 1 mg tablet, 30 |
1263L | Bisalax, OX – BISACODYL, bisacodyl 10 mg/5 mL enema, 25 x 5 mL |
12114N | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 1 g injection, 10 vials |
1788D | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 1 g injection, 5 vials |
1357K | Dosulepin Mylan, AL – DOSULEPIN (DOTHIEPIN), dosulepin (dothiepin) hydrochloride 25 mg capsule, 50 |
13369P | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 5 mg tablet, 30 |
13465Q | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 10 mg tablet, 30 |
1368B | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 10 mg tablet, 30 |
1370D | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 5 mg tablet, 30 |
9024Y | Nizoral 2% Cream, JT – KETOCONAZOLE, ketoconazole 2% cream, 30 g |
14000W | Noumed Mycophenolate, VO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
8650G | Noumed Mycophenolate, VO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
13441K | Nebivolol Viatris, AL – NEBIVOLOL, nebivolol 10 mg tablet, 28 |
13568D | Nebivolol Viatris, AL – NEBIVOLOL, nebivolol 1.25 mg tablet, 28 |
9312D | Nebivolol Viatris, AL – NEBIVOLOL, nebivolol 10 mg tablet, 28 |
9316H | Nebivolol Viatris, AL – NEBIVOLOL, nebivolol 1.25 mg tablet, 28 |
13921Q | NOUMED PIOGLITAZONE, VO – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
13921Q | Pioglitazone Sandoz, SZ – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
14057W | NOUMED PIOGLITAZONE, VO – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
14057W | Pioglitazone Sandoz, SZ – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
8695P | NOUMED PIOGLITAZONE, VO – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
8695P | Pioglitazone Sandoz, SZ – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
8696Q | NOUMED PIOGLITAZONE, VO – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
8696Q | Pioglitazone Sandoz, SZ – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
13406N | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
13586C | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
13588E | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
13589F | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
2574L | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
2594M | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
2606E | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
2628H | Noumed Rosuvastatin, VO – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
5480K | NOUMED VALACICLOVIR, VO – VALACICLOVIR, valaciclovir 500 mg tablet, 30 |
8134D | NOUMED VALACICLOVIR, VO – VALACICLOVIR, valaciclovir 500 mg tablet, 30 |
1 July 2024
Deletion – Brand
12117R | Calquence, AP – ACALABRUTINIB, acalabrutinib 100 mg capsule, 56 |
12826C | Calquence, AP – ACALABRUTINIB, acalabrutinib 100 mg capsule, 56 |
8717T | Aripic Aripiprazole, LR – ARIPIPRAZOLE, aripiprazole 10 mg tablet, 30 |
13468W | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 40 mg tablet, 30 |
13495G | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 10 mg tablet, 30 |
8213G | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 10 mg tablet, 30 |
8215J | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 40 mg tablet, 30 |
13436E | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 8 mg tablet, 30 |
13438G | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 32 mg tablet, 30 |
13565Y | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 16 mg tablet, 30 |
13592J | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 4 mg tablet, 30 |
8295N | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 4 mg tablet, 30 |
8296P | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 8 mg tablet, 30 |
8297Q | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 16 mg tablet, 30 |
8889W | NOUMED CANDESARTAN, VO – CANDESARTAN, candesartan cilexetil 32 mg tablet, 30 |
11169W | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 2 g injection, 5 vials |
12112L | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 2 g injection, 10 vials |
3138E | Clindamycin BNM, BZ – CLINDAMYCIN, clindamycin 150 mg capsule, 24 |
5057E | Clindamycin BNM, BZ – CLINDAMYCIN, clindamycin 150 mg capsule, 24 |
3118D | Depo-Ralovera, FZ – MEDROXYPROGESTERONE, medroxyprogesterone acetate 150 mg/mL injection, 1 mL vial |
12109H | Asmol CFC-Free with dose counter, AF – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
12109H | Zempreon CFC-Free with dose counter, AL – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
12670W | Terrosa, FX – TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL cartridge |
13891D | Terrosa, FX – TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL cartridge |
13913G | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 50 mg tablet, 60 |
13969F | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 25 mg tablet, 60 |
14008G | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 100 mg tablet, 60 |
14009H | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 200 mg tablet, 60 |
8163P | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 25 mg tablet, 60 |
8164Q | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 50 mg tablet, 60 |
8165R | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 100 mg tablet, 60 |
8166T | NOUMED TOPIRAMATE, VO – TOPIRAMATE, topiramate 200 mg tablet, 60 |
1 August 2024
Deletion – Brand
8357W | Acamprosate Mylan, AL – ACAMPROSATE, acamprosate calcium 333 mg enteric tablet, 180 |
13955L | Acarbose Mylan, AF – ACARBOSE, acarbose 50 mg tablet, 90 |
8188Y | Acarbose Mylan, AF – ACARBOSE, acarbose 50 mg tablet, 90 |
12115P | Cephazolin Alphapharm, AF – CEFAZOLIN, cefazolin 2 g injection, 10 vials |
12118T | Cephazolin Alphapharm, AF – CEFAZOLIN, cefazolin 2 g injection, 10 vials |
9159C | Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28 |
13884R | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
14000W | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
8649F | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
8650G | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
2335X | Cipla Pregabalin, LR – PREGABALIN, pregabalin 75 mg capsule, 56 |
2348N | Cipla Pregabalin, LR – PREGABALIN, pregabalin 25 mg capsule, 56 |
2363J | Cipla Pregabalin, LR – PREGABALIN, pregabalin 300 mg capsule, 56 |
Palliative Care
Alterations
Alteration – Manufacturer Code
From | To | ||
12549L | Ordine 5 – MORPHINE, morphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL | MF | XT |
12472K | Ordine 10 – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL | MF | XT |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
14106K | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14110P | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14115X | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14119D | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14136B | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14107L | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
14127M | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
14143J | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Addition – Brand
9681M | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
9682N | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11920J | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
9683P | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
Addition – Equivalence Indicator
9681M | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
9682N | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11920J | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
9683P | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
Deletions
Deletion – Note
12201E | AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Mylan, Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12180C | AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12148J | BOSENTAN, bosentan 62.5 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Mylan, Bosentan RBX, Tracleer) |
12146G | BOSENTAN, bosentan 125 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Cipla, Bosentan GH, Bosentan Mylan, Bosentan RBX, Tracleer) |
13163T | BUROSUMAB, burosumab 10 mg/mL injection, 1 mL vial (Crysvita) |
13136J | BUROSUMAB, burosumab 20 mg/mL injection, 1 mL vial (Crysvita) |
13154H | BUROSUMAB, burosumab 30 mg/mL injection, 1 mL vial (Crysvita) |
10111E | EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri) |
11069N | EPOPROSTENOL, epoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
10129D | EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri) |
11082G | EPOPROSTENOL, epoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
6456T | ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis) |
12135Q | MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit) |
13197N | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
12138W | SILDENAFIL, sildenafil 20 mg tablet, 90 (Revatio, SILDATIO PHT, Sildenafil PHT APOTEX, Sildenafil Sandoz PHT 20) |
12150L | TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, TADALIS 20, Tadalca) |
Deletion – Restriction
12201E | AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Mylan, Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12180C | AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12148J | BOSENTAN, bosentan 62.5 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Mylan, Bosentan RBX, Tracleer) |
12146G | BOSENTAN, bosentan 125 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Cipla, Bosentan GH, Bosentan Mylan, Bosentan RBX, Tracleer) |
13163T | BUROSUMAB, burosumab 10 mg/mL injection, 1 mL vial (Crysvita) |
13136J | BUROSUMAB, burosumab 20 mg/mL injection, 1 mL vial (Crysvita) |
13154H | BUROSUMAB, burosumab 30 mg/mL injection, 1 mL vial (Crysvita) |
10111E | EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri) |
11069N | EPOPROSTENOL, epoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
10129D | EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri) |
11082G | EPOPROSTENOL, epoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
6456T | ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis) |
12135Q | MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit) |
13197N | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
12138W | SILDENAFIL, sildenafil 20 mg tablet, 90 (Revatio, SILDATIO PHT, Sildenafil PHT APOTEX, Sildenafil Sandoz PHT 20) |
12150L | TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, TADALIS 20, Tadalca) |
Advance Notices
1 June 2024
Deletion – Brand
12201E | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
9648T | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
12139X | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12143D | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12146G | Tracleer, JC – BOSENTAN, bosentan 125 mg tablet, 60 |
12148J | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
6429J | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
6430K | Tracleer, JC – BOSENTAN, bosentan 125 mg tablet, 60 |
6209T | Noumed Mycophenolate, VO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
1 August 2024
Deletion – Brand
12146G | Bosentan Cipla, LR – BOSENTAN, bosentan 125 mg tablet, 60 |
6430K | Bosentan Cipla, LR – BOSENTAN, bosentan 125 mg tablet, 60 |
11888Q | Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28 |
9627Q | Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28 |
6208R | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
6209T | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
14140F | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14141G | DIFELIKEFALIN, difelikefalin 50 microgram/mL injection, 12 x 1 mL vials (Korsuva) |
14120E | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14128N | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14144K | ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade) |
14112R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
14121F | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
14131R | ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade) |
Addition – Brand
9664P | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
9665Q | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11907Q | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
9666R | Tacrolimus XR Sandoz, SZ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
Addition – Equivalence Indicator
9664P | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 500 microgram modified release capsule, 30 |
9665Q | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 1 mg modified release capsule, 60 |
11907Q | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 3 mg modified release capsule, 50 |
9666R | ADVAGRAF XL, LQ – TACROLIMUS, tacrolimus 5 mg modified release capsule, 30 |
Deletions
Deletion – Note
12212R | AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Mylan, Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12186J | AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12145F | BOSENTAN, bosentan 62.5 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Mylan, Bosentan RBX, Tracleer) |
12149K | BOSENTAN, bosentan 125 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Cipla, Bosentan GH, Bosentan Mylan, Bosentan RBX, Tracleer) |
13140N | BUROSUMAB, burosumab 10 mg/mL injection, 1 mL vial (Crysvita) |
13145W | BUROSUMAB, burosumab 20 mg/mL injection, 1 mL vial (Crysvita) |
13155J | BUROSUMAB, burosumab 30 mg/mL injection, 1 mL vial (Crysvita) |
10130E | EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri) |
11090Q | EPOPROSTENOL, epoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
10117L | EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri) |
11065J | EPOPROSTENOL, epoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
5751Q | ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis) |
12147H | MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit) |
13185Y | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
12144E | SILDENAFIL, sildenafil 20 mg tablet, 90 (Revatio, SILDATIO PHT, Sildenafil PHT APOTEX, Sildenafil Sandoz PHT 20) |
12151M | TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, TADALIS 20, Tadalca) |
Deletion – Restriction
12212R | AMBRISENTAN, ambrisentan 5 mg tablet, 30 (Ambrisentan Mylan, Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12186J | AMBRISENTAN, ambrisentan 10 mg tablet, 30 (Ambrisentan Viatris, Cipla Ambrisentan, PULMORIS, Volibris) |
12145F | BOSENTAN, bosentan 62.5 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Mylan, Bosentan RBX, Tracleer) |
12149K | BOSENTAN, bosentan 125 mg tablet, 60 (BOSENTAN DR.REDDY'S, BOSLEER, Bosentan APO, Bosentan Cipla, Bosentan GH, Bosentan Mylan, Bosentan RBX, Tracleer) |
13140N | BUROSUMAB, burosumab 10 mg/mL injection, 1 mL vial (Crysvita) |
13145W | BUROSUMAB, burosumab 20 mg/mL injection, 1 mL vial (Crysvita) |
13155J | BUROSUMAB, burosumab 30 mg/mL injection, 1 mL vial (Crysvita) |
10130E | EPOPROSTENOL, epoprostenol 500 microgram injection, 1 vial (Veletri) |
11090Q | EPOPROSTENOL, epoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
10117L | EPOPROSTENOL, epoprostenol 1.5 mg injection, 1 vial (Veletri) |
11065J | EPOPROSTENOL, epoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack (Flolan) |
5751Q | ILOPROST, iloprost 20 microgram/2 mL inhalation solution, 30 x 2 mL ampoules (Ventavis) |
12147H | MACITENTAN, macitentan 10 mg tablet, 30 (Opsumit) |
13185Y | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
12144E | SILDENAFIL, sildenafil 20 mg tablet, 90 (Revatio, SILDATIO PHT, Sildenafil PHT APOTEX, Sildenafil Sandoz PHT 20) |
12151M | TADALAFIL, tadalafil 20 mg tablet, 56 (Adcirca, TADALIS 20, Tadalca) |
Advance Notices
1 June 2024
Deletion – Brand
12212R | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
5607D | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
12134P | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12140Y | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12145F | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12149K | Tracleer, JC – BOSENTAN, bosentan 125 mg tablet, 60 |
5618Q | Tracleer, JC – BOSENTAN, bosentan 62.5 mg tablet, 60 |
5619R | Tracleer, JC – BOSENTAN, bosentan 125 mg tablet, 60 |
9502D | Noumed Mycophenolate, VO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
1 August 2024
Deletion – Brand
12149K | Bosentan Cipla, LR – BOSENTAN, bosentan 125 mg tablet, 60 |
5619R | Bosentan Cipla, LR – BOSENTAN, bosentan 125 mg tablet, 60 |
11885M | Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28 |
5623Y | Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28 |
9501C | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
9502D | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
Highly Specialised Drugs Program (Community Access)
Deletions
Deletion – Brand
11149T | Tenofovir Disoproxil Emtricitabine Mylan 300/200, AF – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 |
Advance Notices
1 June 2024
Deletion – Brand
10284G | Lamivudine 150 mg + Zidovudine 300 mg Alphapharm, AF – LAMIVUDINE + ZIDOVUDINE, lamivudine 150 mg + zidovudine 300 mg tablet, 60 |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
14109N |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
14133W |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Deletions
Deletion – Item
12221F |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Deletion – Note
13153G |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletion – Restriction
13153G |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Alterations
Alteration – Manufacturer Code
From | To | ||
13135H | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13153G | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13160P | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13162R | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
Advance Notices
1 June 2024
Deletion – Brand
12219D | Velcade, JC – BORTEZOMIB, bortezomib 1 mg injection, 1 vial |
12219D | Velcade, JC – BORTEZOMIB, bortezomib 3 mg injection, 1 vial |
12219D | Velcade, JC – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
14122G |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
14130Q |
DOSTARLIMAB, dostarlimab 500 mg/10 mL injection, 10 mL vial (Jemperli) |
Deletions
Deletion – Item
12229P |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Deletion – Note
13159N |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletion – Restriction
13159N |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Alterations
Alteration – Manufacturer Code
From | To | ||
13152F | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13159N | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13161Q | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
13169D | Libtayo – CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial | SW | WM |
Advance Notices
1 June 2024
Deletion – Brand
12227M | Velcade, JC – BORTEZOMIB, bortezomib 1 mg injection, 1 vial |
12227M | Velcade, JC – BORTEZOMIB, bortezomib 3 mg injection, 1 vial |
12227M | Velcade, JC – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
Related Pharmaceutical Benefits for Public Hospital use
Deletions
Deletion – Note
13201T | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
Deletion – Restriction
13201T | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |